Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThis update adds an NIH grant/contract line to the study's identifiers, indicating funding support for the trial.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page shows a revision bump from v3.6.3 to v3.6.4, indicating a small software update with no visible changes to the study details content.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.1 to Revision: v3.6.3, indicating a new revision of the page's metadata.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision label changed from v3.6.0 to v3.6.1, indicating a minor update to the page metadata. This likely represents a small patch or improvement without altering the study content.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now signals that recruitment is closed with 'No longer looking for participants' and adds new help/join-related navigation items. The Publications section includes a new 2026 Lebrikizumab reference and the revision label updates to v3.6.0, while an older 'Intervention / Treatment' heading and a previous publication citation were removed.SummaryDifference0.2%

Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.